Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urologic Neoplasms × poly ICLC × Clear all

Sponsor

Conditions

Melanoma 6 Glioma 4 Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Central Nervous System Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Metastatic Castration-resistant Prostate Cancer 1 Medulloblastoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Gliosarcoma 1

Interventions

Trastuzumab 2 valrubicin 1 niraparib 1 enfortumab vedotin 1 avelumab 1 Surveys and Questionnaires 1 Sunitinib 1 Sugammadex 1 Standard of Care 1 Paclitaxel 1 Neostigmine 1 Neoadjuvant Therapy 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Cetuximab 1 Afatinib 1 Administration, Intravesical 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡